U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07425145) titled 'Transcutaneous Electrical Acustimulation for IBS-D: A Multicenter Study' on Feb. 13.
Brief Summary: Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent abdominal pain and altered bowel habits. Under the Rome IV criteria, IBS can be classified into constipation-predominant (IBS-C), diarrhea-predominant (IBS-D), mixed (IBS-M), and unclassified (IBS-U) subtypes. IBS-D represents one of the most clinically disruptive phenotypes due to the combined burden of abdominal pain and frequent loose stools1. These symptoms are the major drivers of impaired quality of life and healthcare utilization...